Free Trial

Extendicare Inc. (TSE:EXE) Announces $0.04 Quarterly Dividend

Extendicare logo with Medical background

Key Points

  • Extendicare Inc. declared a quarterly dividend of C$0.04 per share, payable on September 15th to shareholders of record as of August 29th, resulting in an annualized yield of 1.3%.
  • Extendicare's stock has been trading at C$12.66, with a market cap of C$1.06 billion and significant growth potential indicated by analysts, who have set price targets ranging from C$14.50 to C$15.40.
  • The company's performance shows a current ratio of 0.62 and a high debt-to-equity ratio of 283.02, raising potential concerns about financial stability compared to growth forecasts.
  • Looking to export and analyze Extendicare data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Extendicare Inc. (TSE:EXE - Get Free Report) declared a quarterly dividend on Wednesday, August 6th, RTT News reports. Stockholders of record on Friday, August 29th will be given a dividend of 0.042 per share on Monday, September 15th. This represents a c) dividend on an annualized basis and a dividend yield of 1.3%.

Extendicare Price Performance

Shares of TSE EXE traded up C$0.50 during mid-day trading on Friday, reaching C$13.17. The company's stock had a trading volume of 374,084 shares, compared to its average volume of 187,421. The company has a debt-to-equity ratio of 283.02, a current ratio of 0.62 and a quick ratio of 0.98. The firm has a market capitalization of C$1.10 billion, a PE ratio of 16.79 and a beta of 1.26. Extendicare has a 52 week low of C$7.58 and a 52 week high of C$15.24. The stock has a fifty day moving average of C$13.47 and a two-hundred day moving average of C$13.02.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

Read More

Dividend History for Extendicare (TSE:EXE)

Should You Invest $1,000 in Extendicare Right Now?

Before you consider Extendicare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.

While Extendicare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines